Source:http://linkedlifedata.com/resource/pubmed/id/17693990
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11
|
pubmed:dateCreated |
2007-10-11
|
pubmed:abstractText |
Most advanced solid tumors metastasize to different organs. However, no gene therapy effective for multiple tumors has yet been developed. Since a unique characteristic of bone marrow-derived mesenchymal stem cells (MSCs) is that they migrate to tumor tissues, we wanted to determine whether MSCs could serve as a vehicle of gene therapy for targeting multiple tumors. First, we confirmed that mouse MSCs preferentially migrate to multiple tumors of the lung in the Colon-26 (C-26) lung metastasis model. Next, MSCs were efficiently transduced with NK4, an antagonist of hepatocyte growth factor (HGF), by an adenoviral vector with an RGD motif. MSCs expressing NK4 (NK4-MSCs) strongly inhibited development of lung metastases in the C-26 lung metastasis model after systemic administration via a tail vein. Treatment with NK4-MSCs significantly prolonged survival of the C-26-tumor-bearing mice by inhibiting tumor-associated angiogenesis and lymphangiogenesis and inducing apoptosis of the tumor cells. MSC-based gene therapy did not induce the severe adverse effects induced by conventional adenoviral vectors. These results indicate that MSCs can serve as a vehicle of gene therapy for targeting multiple lung metastatic tumors.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0929-1903
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
14
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
894-903
|
pubmed:meshHeading |
pubmed-meshheading:17693990-Adenoviridae,
pubmed-meshheading:17693990-Animals,
pubmed-meshheading:17693990-Apoptosis,
pubmed-meshheading:17693990-Bone Marrow Cells,
pubmed-meshheading:17693990-Cell Movement,
pubmed-meshheading:17693990-Gene Therapy,
pubmed-meshheading:17693990-Hepatocyte Growth Factor,
pubmed-meshheading:17693990-Humans,
pubmed-meshheading:17693990-Lung Neoplasms,
pubmed-meshheading:17693990-Lymphangiogenesis,
pubmed-meshheading:17693990-Mesenchymal Stem Cell Transplantation,
pubmed-meshheading:17693990-Mesenchymal Stem Cells,
pubmed-meshheading:17693990-Mice,
pubmed-meshheading:17693990-Mice, Inbred BALB C,
pubmed-meshheading:17693990-Neovascularization, Pathologic
|
pubmed:year |
2007
|
pubmed:articleTitle |
Targeted delivery of NK4 to multiple lung tumors by bone marrow-derived mesenchymal stem cells.
|
pubmed:affiliation |
Department of Molecular Medicine, Tohoku University Graduate School of Medicine, 2-1 Seiryomachi Aobaku, Sendai, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|